The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management

Por Panebianco, Federica, Mazzanti, Chiara, Tomei, Sara, Aretini, Paolo, Franceschi, Sara, Lessi, Francesca, Di Coscio, Giancarlo, Bevilacqua, Generoso, Marchetti, Ivo
Publicado no BMC Cancer (2015)

Loss of c-KIT expression in thyroid cancer cells

Por Franceschi, Sara, Lessi, Francesca, Panebianco, Federica, Tantillo, Elena, La Ferla, Marco, Menicagli, Michele, Aretini, Paolo, Apollo, Alessandro, Naccarato, Antonio Giuseppe, Marchetti, Ivo, Mazzanti, Chiara Maria
Publicado no PLoS One (2017)

Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer

Por Kelly, Lindsey M., Barila, Guillermo, Liu, Pengyuan, Evdokimova, Viktoria N., Trivedi, Sumita, Panebianco, Federica, Gandhi, Manoj, Carty, Sally E., Hodak, Steven P., Luo, Jianhua, Dacic, Sanja, Yu, Yan P., Nikiforova, Marina N., Ferris, Robert L., Altschuler, Daniel L., Nikiforov, Yuri E.
Publicado em 2014

THADA fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer

Por Panebianco, Federica, Kelly, Lindsey M., Liu, Pengyuan, Zhong, Shan, Dacic, Sanja, Wang, Xiaosong, Singhi, Aatur D., Dhir, Rajiv, Chiosea, Simion I., Kuan, Shih-Fan, Bhargava, Rohit, Dabbs, David, Trivedi, Sumita, Gandhi, Manoj, Diaz, Rachel, Wald, Abigail I., Carty, Sally E., Ferris, Robert L., Lee, Adrian V., Nikiforova, Marina N., Nikiforov, Yuri E.
Publicado no Proc Natl Acad Sci U S A (2017)